Table 2 Lipidomic analysis of control (T0 and T2) and treated (different GO concentrations, BSA, MβCD) samples. Values expressed as standard deviation.
Fatty Acids | T0 | T2 | H2O2 | BSA | MBCD | GO 0.5 | GO 1 | GO 1.5 | GO 2.5 | GO 5 |
---|---|---|---|---|---|---|---|---|---|---|
C14:0 | 0.351 | 1.113 | 0.798 | 1.408 | 0.996 | 1.431 | 1.299 | 1.542 | 1.000 | 1.099 |
Palmitic (C16:0) | 0.728 | 3.219 | 0.385 | 1.066 | 0.895 | 0.730 | 1.103 | 0.235 | 1.631 | 1.452 |
Stearic (C18:0) | 0.979 | 2.760 | 1.228 | 1.430 | 0.650 | 0.992 | 0.837 | 0.593 | 0.863 | 0.876 |
Oleic (C18:1 n-9) | 0.155 | 0.925 | 0.779 | 0.229 | 0.785 | 0.486 | 1.069 | 1.099 | 1.617 | 2.391 |
Vaccenic (C18:1) n-7 | 0.180 | 0.103 | 0.042 | 0.012 | 0.066 | 0.059 | 0.090 | 0.149 | 0.042 | 0.075 |
Cis-Linoleic (C18:2 n-6) | 0.437 | 0.445 | 0.460 | 0.332 | 0.498 | 0.521 | 0.662 | 0.734 | 0.327 | 0.458 |
DGLA (C20:3 n-6) | 0.289 | 0.297 | 0.131 | 0.102 | 0.153 | 0.169 | 0.229 | 0.263 | 0.173 | 0.184 |
AA (C20:4 n-6) | 0.242 | 0.158 | 0.056 | 0.071 | 0.076 | 0.111 | 0.118 | 0.115 | 0.121 | 0.111 |
C22:4 n-6 | 0.085 | 0.321 | 0.111 | 0.176 | 0.304 | 0.112 | 0.085 | 0.101 | 0.036 | 0.032 |
C22:5 n-6 | 0.736 | 3.668 | 1.425 | 2.348 | 1.018 | 1.943 | 0.261 | 1.558 | 1.266 | 0.375 |
DHA (C22:6 n-3) | 1.531 | 3.865 | 0.422 | 0.621 | 0.877 | 0.179 | 1.565 | 1.739 | 0.297 | 1.155 |
SFA | 1.078 | 6.764 | 2.407 | 3.419 | 2.085 | 3.013 | 1.465 | 2.095 | 2.482 | 2.087 |
MUFA | 0.100 | 0.984 | 0.760 | 0.217 | 0.813 | 0.512 | 1.056 | 1.094 | 1.595 | 2.349 |
PUFA | 0.989 | 7.627 | 1.742 | 3.559 | 1.424 | 2.993 | 0.590 | 2.912 | 1.490 | 0.276 |
SFA/MUFA | 0.452 | 0.465 | 0.921 | 0.602 | 0.652 | 0.489 | 0.664 | 0.314 | 0.570 | 0.487 |
OMEGA-6/OMEGA-3 | 0.155 | 0.121 | 0.116 | 0.089 | 0.141 | 0.114 | 0.152 | 0.153 | 0.105 | 0.139 |
Peroxidation Index | 10.0 | 53.1 | 6.6 | 20.2 | 5.9 | 14.7 | 10.2 | 19.1 | 6.2 | 5.9 |
Insaturation index | 6.0 | 33.3 | 5.4 | 13.4 | 4.8 | 10.0 | 6.0 | 11.2 | 5.2 | 2.7 |